Four months after Lori Cuffari entered a clinical trial for Hurthle cell carcinoma—an aggressive form of thyroid cancer—the investigational medication Lenvima was approved by the FDA for use in the United States. Her experience illustrates the spectacular progress being made against cancer and highlights the need for continued federal funding of cancer research. http://www.CancerProgressRe...
Cancer research from fundamental science to clinical trials has a direct impact on the lives of real people. Watch their videos and read about their journeys from diagnosis to survivorship: http://www.AACRFoundation.org/survivors.
The AACR’s fifth annual Cancer Progress Report highlights how federally funded research can power progress against cancer. The report details how federally funded research is improving lives and contains a special section showcasing the remarkable advances made against cancer in the five years of publishing the report. Learn more at http://www.CancerProgressReport.org.
From the basic science labs to cancer clinics around the world, innovative scientists are transforming our approaches to prevention and treatments. Learn more here: http://www.AACRFoundation.org/scientists.